127 related articles for article (PubMed ID: 38205615)
21. Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems.
Hartkamp A; van Boxtel AJ; Zonnenberg BA; Witteveen PO
Neth J Med; 2000 Dec; 57(6):215-23. PubMed ID: 11099790
[TBL] [Abstract][Full Text] [Related]
22. Totally implantable venous access device placement by interventional radiologists: are prophylactic antibiotics necessary?
Covey AM; Toro-Pape FW; Thornton RH; Son C; Erinjeri J; Sofocleous CT; Brody LA; Brown KT; Sepkowitz KA; Getrajdman GI
J Vasc Interv Radiol; 2012 Mar; 23(3):358-62. PubMed ID: 22365295
[TBL] [Abstract][Full Text] [Related]
23. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
24. Clinical review and analysis of complications of totally implantable venous access devices for chemotherapy.
Kim JT; Oh TY; Chang WH; Jeong YK
Med Oncol; 2012 Jun; 29(2):1361-4. PubMed ID: 21380779
[TBL] [Abstract][Full Text] [Related]
25. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
26. Quality-of-life assessment: arm TIVAD versus chest TIVAD.
Burbridge B; Goyal K
J Vasc Access; 2016 Nov; 17(6):527-534. PubMed ID: 27768211
[TBL] [Abstract][Full Text] [Related]
27. Infections associated with totally implantable venous access devices (TIVAD) in human immunodeficiency virus-infected patients.
Dega H; Eliaszewicz M; Gisselbrecht M; Fleury J; Pialoux G; Janssen B; de Saint-Martin L; Gonzalez-Canali G; Dupont B
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Oct; 13(2):146-54. PubMed ID: 8862279
[TBL] [Abstract][Full Text] [Related]
28. Incidence of and risk factors for totally implantable vascular access device complications in patients with gastric cancer: A retrospective analysis.
Okazaki M; Oyama K; Kinoshita J; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
Mol Clin Oncol; 2019 Oct; 11(4):343-348. PubMed ID: 31475061
[TBL] [Abstract][Full Text] [Related]
29. Totally implantable venous access device in children with cancer lead to disfiguring scar.
Braam KI; Veening MA; Schouten-van Meeteren AY; van Dulmen-den Broeder E; Heij HA
Pediatr Hematol Oncol; 2013 Mar; 30(2):154-64. PubMed ID: 23302017
[TBL] [Abstract][Full Text] [Related]
30. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.
Burbridge B; Plewes C; Stoneham G; Szkup P; Otani R; Babyn P; Bryce R
J Vasc Interv Radiol; 2018 May; 29(5):648-656.e3. PubMed ID: 29499999
[TBL] [Abstract][Full Text] [Related]
31. Is there any effect of first-day usage of a totally implantable venous access device on complications?
Karanlik H; Odabas H; Yildirim I; Ozgur I; Kilic B; Sen F; Kurul S; Aydiner A
Int J Clin Oncol; 2015 Dec; 20(6):1057-62. PubMed ID: 25911604
[TBL] [Abstract][Full Text] [Related]
32. Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution.
Shankar G; Jadhav V; Ravindra S ; Babu N; Ramesh S
Indian J Surg Oncol; 2016 Sep; 7(3):326-31. PubMed ID: 27651694
[TBL] [Abstract][Full Text] [Related]
33. Effects of prolonged flushing interval in totally implantable venous access devices (TIVADs).
Rasero L; Golin L; Ditta S; Di Massimo DS; Dal Molin A; Piemonte G
Br J Nurs; 2018 Apr; 27(8):S4-S10. PubMed ID: 29683741
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound-guided totally implantable venous access device through the right innominate vein in older patients is safe and reliable.
Sun X; Zhang Y; Yang C; Zhou Y; Bai X; Zheng W; Jin Y
Geriatr Gerontol Int; 2019 Mar; 19(3):218-221. PubMed ID: 30724007
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous bacterial colonization, modalities of chemotherapeutic infusion, and catheter-related bloodstream infection in totally implanted venous access devices.
Laurenzi L; Natoli S; Benedetti C; Marcelli ME; Tirelli W; DiEmidio L; Arcuri E
Support Care Cancer; 2004 Nov; 12(11):805-9. PubMed ID: 15372220
[TBL] [Abstract][Full Text] [Related]
36. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
Goossens GA; Stas M; Moons P
Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
[TBL] [Abstract][Full Text] [Related]
37. Pinch-Off Syndrome, a Rare Complication of Totally Implantable Venous Access Device Implantation: A Case Series and Literature Review.
Ilhan BM; Sormaz İC; Türkay R
Korean J Thorac Cardiovasc Surg; 2018 Oct; 51(5):333-337. PubMed ID: 30402393
[TBL] [Abstract][Full Text] [Related]
38. Totally implantable vascular access devices in 131 pediatric oncology patients.
Sola JE; Stone MM; Colombani PM
Pediatr Surg Int; 1996 Mar; 11(2-3):156-8. PubMed ID: 24057543
[TBL] [Abstract][Full Text] [Related]
39. Surgical placement of totally implantable venous access device-an institutional experience.
Chandrasekaran A; Somasundaram J
Indian J Pediatr; 2014 Sep; 81(9):866-70. PubMed ID: 23943575
[TBL] [Abstract][Full Text] [Related]
40. [Complications with totally implantable venous access device. A retrospective of 116 cases].
Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
